GSK PLC reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/20/2022ACC: 0001387131-22-009897
-9.64M
Net shares
Net seller
$94.04M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
9.64M disposed
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
−9.64M
Price / share
$9.75
Trade value
$94.04M
% of position
New position
9/16/2022
9.64M→0.00
Total
Net shares
−9.64M
Net value
-$94.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 9/16/2022 | J · J | −9.64M | $9.75 | $94.04M | New position | 9.64M | 0.00 |
| Total | −9.64M | -$94.04M | ||||||
Derivative Transactions1
Exchangeable Senior Notes due 2023
Indirect
Converts to
Ordinary Shares
9.26M shares
Shares
+N/A
Strike price
29.066
Held after
0.00
Exercisable
—
9/16/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Exchangeable Senior Notes due 2023 Indirect | Ordinary Shares9.26M shares | 9/16/2022 | J · J | +N/A | 29.066 | — | 0.00 |